BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1311784)

  • 1. [Treatment of gastric ulcers with proton pump inhibitors--long-term treatment].
    Aoki T; Akimoto H; Takayama S
    Nihon Rinsho; 1992 Jan; 50(1):181-7. PubMed ID: 1311784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810)].
    Kawai T; Ikeda H; Harada Y; Saitou T
    Nihon Rinsho; 1992 Jan; 50(1):188-93. PubMed ID: 1311785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [H2-receptor antagonist-refractory ulcer--its pathophysiology and role of proton-pump inhibitors].
    Arakawa T
    Nihon Rinsho; 1992 Jan; 50(1):122-30. PubMed ID: 1347325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristic features of proton pump inhibitors in the inhibition of gastric acid secretion: long-acting and complete inhibition].
    Ohe K
    Nihon Rinsho; 1992 Jan; 50(1):45-52. PubMed ID: 1311789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].
    Okabe S
    Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):351-60. PubMed ID: 2873085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer].
    Asaki S; Kimpara T; Ohara S; Hongo M
    Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
    Karasawa H; Miwa T
    Nihon Rinsho; 1992 Jan; 50(1):74-80. PubMed ID: 1347333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M; Kato M; Sato Y; Miyazaki T
    Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the intracellular pharmacodynamic properties of proton pump inhibitors and the inhibitory mechanism of acid secretion].
    Saito E; Matsuo Y
    Nihon Rinsho; 1992 Jan; 50(1):18-25. PubMed ID: 1311783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton pump inhibitors: their merits and demerits, and perspectives for future investigation].
    Kamada T; Kawano S; Tsuji S
    Nihon Rinsho; 1992 Jan; 50(1):53-9. PubMed ID: 1347330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
    Nagaya H; Satoh H
    Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the therapeutic use of proton pump inhibitor (PPI) by measurement of 24 hour the intra-gastric pH].
    Yamagata S
    Nihon Rinsho; 1992 Jan; 50(1):160-6. PubMed ID: 1347328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endoscopic studies on refractory gastric ulcers, especially, linear ulcers, treated with proton pump inhibitor].
    Takase S; Takada A
    Nihon Rinsho; 1992 Jan; 50(1):116-21. PubMed ID: 1347324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
    McArthur KE; Jensen RT; Gardner JD
    Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
    Yoshino J; Nakazawa S; Nakamura T; Yamao K; Inui K; Yamachika H; Watanabe K; Wakabayashi T
    Nihon Rinsho; 1992 Jan; 50(1):81-5. PubMed ID: 1347334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gastric H+,K+-ATPase: the site of action of omeprazole.
    Sachs G; Wallmark B
    Scand J Gastroenterol Suppl; 1989; 166():3-11. PubMed ID: 2557669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnifying endoscopic observation on the effect of a proton pump inhibitor on the healing process of gastric ulcer].
    Sakaki N
    Nihon Rinsho; 1992 Jan; 50(1):86-93. PubMed ID: 1311790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.